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Background: The consumption of flavonoids has been shown to prevent cardiovascular diseases 
including atherosclerosis. In this sense, in a recent in vitro study we demonstrated that a rich in 
flavonoids extract from Zuccagnia punctata has beneficial effects on vascular function in aorta 
from hypercholesterolemic rabbits. 
Purpose: The aim of this study was to evaluate the ability of a hydroalcoholic extract from 
Z.puncata (ZpE) to prevent alterations induced by high cholesterol diet in rabbits.  
Methods: The major components of the ZpE, flavonoids, were analyzed by using a validated 
reversed phase HPLC method. Rabbits were separated in five groups: fed standard chow (CD); CD 
orally administrated 2.5 mg, 5 mg or 10 mg GAE/day ZpE (ZpE- CD); fed 1% cholesterol-enriched 
chow (HD); HD orally administrated 2.5 mg GAE/day ZpE (ZpE-HD); HD orally administrated 2.5 
mg rosuvastatin/day (Ro-HD). All diets were administrated by 6 weeks. Body weights (BW), mean 
blood pressure (MAP), heart rate (HR), visceral abdominal fat (VAF), organ weight (heart, kidney, 
liver) and vascular morphology were determined. Total cholesterol (TC), triglycerides (TG), fasting 
glucose (FG), aspartate amino transferase (AST), alanine amino transferase (ALT), bilirubin, 
creatinine, thiobarbituric acids reactive substances (TBARS) and glutathione reduced/oxidized 
index were measured in serum. Abdominal aorta was excised and vascular function was assessed by 
acetylcholine and sodium nitroprusiate relaxation and contractile response to norepinephrine and 
angiotensin II. 
Results: The major compounds of ZpE identified were chalcones: 2′,4′-dihydroxy-3′-
methoxychalcone and 2′,4′-dihydroxychalcone. Oral treatment with ZpE reduced MAP, TC, TG, 
TBARS, aortic intima/media ratio and increased glutathione reduced/oxidized index in HD rabbits. 
No differences were found in AST, ALT, bilirubin or creatinine. Acetylcholine relaxation was 
normalized and contractile response to norepinephrine and angiotensin II was reduced in ZpE-HD.  
Conclusion: Oral administration of ZpE as natural product in the prevention of cardiovascular 
disease related with hypercholesterolemia and endothelial dysfunction is very promising. 
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Abbreviations:AST: aspartate aminotransferase; ALT: alanine aminotransferase; ACE: angiotensin 
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2′,4′-dihydroxy-3′-methoxychalcone; DMSO: dimethyl sulfoxide;DTNB: 5, 5′-Dithiobis 2-
nitrobenzoic acid; EDNO endothelium-derived nitric oxide; GAE: gallic acid equivalent ; 
GSH:reduced glutathione; GSSG: oxidized glutathione; HD: high cholesterol diet; HDL-C: high 
density lipoprotein cholesterol; HR: heart rate; LDL-C: low density lipoprotein cholesterol; LOX: 
lypooxygenase; MAP: Mean arterial blood pressure; NEFA: non-esterified fatty acids; Rmax: 
maximal response; ROS: reactive oxygen species; SMC: smooth muscle cells; sGC: soluble 
guanylate cyclase; TBARS: thiobarbituric acid reactive substances; TC: total cholesterol; TG: 
















Atherosclerosis, the principal contributor to the pathogenesis of myocardial and cerebral 
infarction, is known to be one of the main causes of morbidity and mortality worldwide (Singh et al. 
2002). Elevated plasma concentration of cholesterol, especially low density lipoprotein (LDL-C), is 
recognized to have a crucial role in the development of atherosclerosis (Maiolino et al. 2013). High 
lipid levels, including triglycerides (TG), non-esterified fatty acids (NEFAs) and LDL-C, damage 
vascular tissues and produce endothelial dysfunction. This condition is known as lipotoxicity (Kin 
et al. 2012). Endothelial dysfunction caused by lipotoxicity is mediated through several mechanisms 
that include increased oxidative stress and pro-inflammatory responses. Impairment of 
endothelium-dependent vasodilation and reduction of nitric oxide (NO) availability are the main 
manifestations of such condition (Jerez et al. 2008).  
The consumption of flavonoids can prevent a number of cardiovascular diseases including 
hypertension and atherosclerosis. Flavonoids from various sources have been reported to prevent 
LDL-C oxidation in vitro and show markedly hypolipidemic activity in vivo, suggesting the 
effectiveness of flavonoids for the prevention and treatment of atherosclerosis (Fuhrman and 
Aviram, 2001; Koshy et al. 2001). Several studies show protective effects of flavonoid-rich diets on 
vascular endothelial function (Hodgson and Craft, 2006). Flavonoids decrease vascular tone and 
agonist-induced contraction in isolated rat arteries through EDNO-sGC-cGMP relaxant pathway 
coupled to stimulation of endogenous NO production from the endothelium (Ajay et al. 2003). 
Chronic administration of antioxidant flavonoids such as quercetin reduces blood pressure as well 
as enhances endothelium dependent relaxation in various animal models of hypertension (Duarte et 
al. 2001; Ajay and Mustafa, 2005). 
Zuccagnia punctata Cav., which belongs to the family of Fabaceae is a monotypic species 
widely distributed in western Argentina (Cabrera, 1971). Z. punctata is reported to have antioxidant 
(Moran Vieyra et al. 2009), anti-inflammatory effects attributed to cyclooxygenase-2 (COX-2) and 
LOX (lypooxygenase) inhibition (Moreno et al. 2015; Nuño et al. 2016), and antigenotoxic 
(Zampini et al. 2008) properties. In addition, phytochemical analysis of Z. punctata shows that it is 
a rich source of flavonoids (flavanones, flavones, chalcones) and caffeoyl esters (Svetaz et al. 2004; 
Moreno et al. 2015). The major constituents from the leaf resin of Z. punctata were of 2´, 
4´dihydroxychalcone and 2´, 4´-dihydroxy-3´-methoxychalcone (Agüero et al. 2010; Moreno et al. 
2015). 
In previous works we characterized a model of hypercholesterolemia by feeding rabbits on a 
high cholesterol diet (HD) by 6 weeks. This model shows hyperlipidemia (Medina et al. 2014), 
increase of oxidative stress and inflammatory markers (Karbiner et al. 2013) and vascular 
dysfunction accompanied by reduction of acetylcholine relaxation and increase of angiotensin II 
reactivity (Jerez et al. 2008). Recently, we demonstrate in vitro beneficial effects of hydroalcoholic 
Z. punctata extract (ZpE) and its major flavonoids on vascular function in hypercholesterolemic 
rabbits (Roco et al. 2017). Thus, the aim of this work was to study the effects of oral treatment with 
a ZpE on our model of hypercholesterolemia. We hypothesized that flavonoid-rich ZpE would have 
beneficial effects on lipid profile, oxidative status and vascular function without any renal, hepatic 
or hematological toxicity. 
 




Z. punctata aerial parts (leaves and stems) were collected (January to February, 2012) from 
the locality of Amaicha del Valle at 2000 meters above sea level (masl), Tucuman, Argentina. The 
samples were dried at room temperature in the dark. Voucher specimens (IML 605935) were kept at 
Miguel Lillo Foundation-Herbarium, Tucumán, Argentina. Dr. Soledad Cuello authenticated the 















Preparation of Zuccagnia punctata extract 
 
20 g of ground air-dried plant material was macerated in 100 ml of ethanol: water (80:20) 
for 7 days with stirring (40 cycles/min) at room temperature.The extract was filtered through 
Whatman No. 4 filter paper. Total phenolic (TP) in the samples were determined according to 
Folin-Ciocalteu method. The non- flavonoid (NFP) and flavonoid (FP) phenolic compounds were 
determined according to Isla et al. (2014) and Popova et al. (2005) respectively. Then, the solvent 
was removed under reduced pressure in a rotary evaporator to obtain a dry ZpE (3.6 g) that was 
stored at -20  °C until further use.TP and NFP were expressed as mg gallic acid equivalent/g dry 




The ZpE was analyzed by HPLC attached to a diode array detector (DAD). The HPLC 
system used for DAD analysis was a Waters equipment (Water Corporation, Milford, 
Massachusetts) consisting of a binary pump 1525, a UV diode array detector 2998, Water X-bridge 
C18 column (150 × 4.6 mm i.d.; 4.6 μm). The HPLC-DAD analyses were performed using a linear 
gradient solvent system consisting of 9% acetic acid in water (A) and methanol (B) as follow: 25 to 
45% B over 10 min, followed by 45% B 10 - 20 min, 45% to 70% B 20 - 40 min, 70% to 75% B 40 
- 50 min, 75% to 100% B 50 - 55 min. The detection was in UV at 280 nm. The flow rate was 0.8 
ml/min and the volume injected was 20 µl. The compounds were monitored at 280, 320 and 350 nm 
and UV spectra from 200 to 600 nm were recorded for peak characterization. The Empower 2TM 
software was used. The UV spectra and co-injection with standards were used to identify the 
flavonoid markers. The major compounds identified were: 2′,4′-dihydroxy-3′-methoxychalcone 
(DHMC) and 2′,4′-dihydroxychalcone (DHC). These compounds were also quantified. A 
calibration curve was prepared by using commercial standards to determine the relationship 





The experimental protocols for this study were approved by the Institutional Animal Care 
and Use Committee (Bioethics Committee of the Medicine School from the National University of 
Tucuman, Argentina).All animal care and use programs were performed according to the Guide for 
the Care and Use of Laboratory Animals (NIH Publication 86 to 23, revised 1985). Male hybrid 
Flanders rabbits were acquired from two recognized local breeders (Cabaña “Los Prieto”, Villa 
Mariano Moreno and Cabaña “Paz”, San Miguel de Tucumán). Animals initially weighing 850-
1,000 g were housed individually in gridded cages on a constant 12-hour light/dark cycle under 
controlled temperature and conditions. They were fed on rabbit chow 100 g/day.Water was given ad 
libitum. Only male rabbits were used to avoid secondary variability related to sex differences in this 
experimental model.The animals were weighed before experimental manipulationand every day 
throughout the period of the experiment. 
 
Diets and treatment 
 
Experiment I: toxicity and doses ranging study in rabbits fed a control diet 
 
After acclimatization period, sixteen rabbits were divided into four groups of four rabbits. 
ZpE was re-dissolved in dimethyl sulfoxide (DMSO, Sigma, USA) prior to use.Three groups were 
administered orally with ZpE suspended in DMSO/water (1:100).The doses of ZpE were 2.5 mg 














1) received the vehicle (DMSO/water, 1:100). The treatments were given once daily at 7 to 8 a.m. 
for 6 weeks. 
The animals were observed continuously during the first hour, and then every hour for 6 h, 
then after12 and 24 h, and finally after every 24 h, up to 6 weeks for any physical signs of toxicity 
such as writhing, gasping, salivation, diarrhea, cyanosis, any nervous manifestations, or mortality. 
 
Measurement of clinical, biochemical, hematological and morphological parameters  
 
At the end of the 6weeks, food was withdrawn for 12 hours; rabbits were weighed and then 
anesthetized with ketamine (20 mg/Kg) and diazepam (0.5 mg/Kg). Mean arterial blood pressure 
(MAP) and heart rate (HR) were measured directly in the carotid artery through a catheter 
connected to a pressure transducer (Gould-Statham P23, California, USA) and recorded using a data 
acquisition system (Biopac MP100, Aero Camino Goleta, USA).  
After MAP measurement, blood samples were collected through the catheter inserted in the 
carotid artery into non-heparinized and EDTA containing tubes for biochemical and hematological 
analyses. Serum was separated by allowing the blood clot at 37 °C and centrifuge at 3000 rpm for 
10 min. Fasting glucose, total cholesterol (TC), triglycerides (TG), creatinine, aspartate 
aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin (total, direct and indirect) 
were measure by using colorimetric reactions with commercial kits (Wiener, Rosario, 
Argentina).The hematological study included white blood count and hematocrit estimation. 
Immediately after the blood collection, the animals were sacrificed for tissue studies. The 
organs such as liver, heart and kidneys, were removed, blotted free of blood and weighed 
immediately. 
 
Experiment II: effect of oral administration of ZpE in rabbits fed a high cholesterol diet  
 
Results from experiment I (Table 1) showed that ZpE 2.5 mg GAE/day was the only dose 
that statistically significantly reduced TC (even in normocholesterolemic rabbits), and did no 
modify hepatic, renal or hematological parameters. For these reasons, 2.5 mg GAE/day was the 
selected dose to study the effect of ZpE in hypercholesterolemic rabbits. After one week 
acclimation period, thirty rabbits were randomly divided into five groups of six rabbits each. 
Animals in group 1 and 2 received a standard chow diet (CD) which is an appropriate maintenance 
diet for a normal adult rabbit (100 g/day). Animals in group 3, 4 and 5 were fed with a diet (100 
g/day) prepared by adding 1% cholesterol (Sigma, St Louis, USA) to standard rabbit diet (HD). 
Groups 2 (ZpE-CD) and 4 (ZpE-HD) were administrated ZpE (2.5 mg GAE/day); Group 5 (positive 
control) received 2.5 mg/day rosuvastatin (Ro-HD). Both ZpE and rosuvastatin were administrated 
orally once daily at 7 to 8 a.m. Animals were fed with appropriate diet and received the treatments 
for 6 weeks.  
Measurements of clinical, biochemical, hematological and morphological parameters were 
performed as was described in previous paragraph (Experiment I). 
 
Effects of oral treatment with 2.5 mg GAE/day of ZpE on oxidative stress parameters 
 
Lipid peroxidation was evaluated by measuring the thiobarbituric acid reactive substances 
(TBARS) and GSH/GSSG was calculated from total glutathione (TGL) and reduced glutathione 
(GSH) levels as was previously described (Karbiner et al. 2013). Briefly, 700 μl of trichloroacetic 
acid 10% was added to 500 μl of serum from rabbits fed a HD or ZpE-HD. The mixture was 
centrifuged (15 min; 10,000 rpm; 4  °C), and the supernatant was used to measurement of TBARS, 
TGL and GSH. The TBARS concentration was calculated using malondialdehyde as a standard. 
The results are expressed as µM. 
To determinate GSH the supernatant was incubated with 0.3 mM NADPH and 6 mM of 














reductase 0.077 U was added and the mixture was incubated 10 min. To calculate TGL, the 
supernatant was incubated 10 min with DTNB 6mM and buffer phosphate pH 7.4. The absorption 
was measure at 412 nm. GSH and TGL were calculated by using GSH standard curve. 
The oxidized glutathione (GSSG) was calculated as GSSG = TGL – GSH.  
Results were expressed as µg/mg proteins determined by the Lowry´s method. 
 
Effects of oral treatment with 2.5 mg GAE/day of ZpE on vascular morphology 
 
Histological analysis of segments of the thoracic aortas (adjacent to the aortic arch) was 
performed. Aortic segments were rinsed with normal saline solution and preserved in 10% 
formaldehyde buffered solution (pH 7.4) for the next step. From each sample, serial sections were 
made (3-5 sections/aorta). The 7 µm sections were stained by haematoxylin-eosin method. Media 
and intima thickness were measured by image analysis with the software Media Cybernetics® 
Image-Pro Plus TM. The ratio between the tunica intima and the tunica media was calculated. A 
code number was assigned to each section observed. 
 
Effects of oral treatment with 2.5 mg GAE/day of ZpE on vascular function 
  
The descending thoracic aorta from the four experimental groups were exposed through a 
midline incision and excised. It was carefully dissected and all adherent fat and connective tissue 
were removed. Five-millimeter wide rings were cut and mounted in a 10 ml organ bath containing 
Krebs solution of the following composition (mM): NaCl 128, KCl 4.7, NaHCO3 14.4, NaH2PO4 
1.2, Na2-EDTA 0.1, CaCl2 2.5, glucose 11.1, pH 7.2. Krebs solution was kept at 37 C and aerated 
with 95% O2 and 5% CO2. 
Isometric contractions were measured by using force-displacement transducers (Grass 
Technologies, West Warwick, USA) and were recorded under an initial tension of 2 g, which had 
been found to be the optimal tension for KCl-induced contraction (96 mM). All preparations were 
allowed to equilibrate for 120 min and were washed with Krebs solution at 15 min intervals.  
In order to check endothelial function after equilibration, aortic rings were pre-contracted 
with phenylephrine (5 x 10
-6





 M) was added cumulatively to the organ bath to construct a 
concentration-response curve (CRC). In other group, only one dose (5 x 10
−6
 M) of the endothelium 
independent vasodilator sodium nitroprusside was used in a similar protocol. The vasodilator effects 
were expressed as percent decrease of the peak phenylephrine contraction. 
To evaluate vascular reactivity, contractile response to agonists was checked. Arteries were 









 M) to construct CRCs. 




Kolmogorov–Smirnov goodness-of-fit test was used to test for normal distribution. Results 
were expressed as mean ± standard error of the mean (SEM) for the number of rabbits. The CRC 
for each experimental condition was plotted and from it were deduced the values of maximal 
response (Rmax) and the concentration of the agonist (expressed as negative log molar) producing 
50% of maximum contraction or relaxation (pEC50) recorded (Prism Version 3.0, GraphPad 
Software, USA).The differences in the mean values between the four diet groupswere tested by two 
way ANOVA followed by a Duncan’stest.The differences in the mean values between ZpE-treated 


















Analysis of flavonoids markers in ZpE 
 
ZpE contained 1215 ± 45 mg GAE/g dry extract of TP compounds. About 53% of TP were 
FP (644 ± 12 mg QE/g dry ZpE) and 47% were NFP (541 ± 15mg GAE/g dry ZpE). The phenolic 
compound profile was performed and the major bioactive compound MDHC and DHC derived 
from them were identified by UV spectra and co-chromatography with the pure compounds 
obtained commercially (Indofine Chemical Company, New Jersey, USA), and quantified by HPLC-
DAD (Fig 1). The quantity of flavonoids was: MDHC: 152.6 ± 5.6 mg/g dry ZpE, DHC: 105.74 ±  
4.79 mg/g dry ZpE. 
MDHC and DHC were chosen as analytical markers of ZpE extracts based on previous 
reports about antioxidant and anti-inflammatory properties of these compounds (Moreno et al. 
2015; Nuño et al. 2016) and recent evidences about the therapeutic potential of chalcones as 
cardiovascular agents (Mahapatra and Bharti, 2016). In addition, in a recent work we demonstrate 
beneficial vascular effect of ZpE and its major flavonoids in aorta from rabbits fed a CD and a HD 
(Roco et al. 2017). 
Measurement of clinical, biochemical and hematological parameters 
Experiment I: toxicity and doses range studies 
No acute toxicity was found by oral administration of ZpE in the form of sedation, itching 
and mortality in experimental rabbits.The body weight (BW) increased in all groups throughout the 
treatment without significant differences among them (data not shown). At the end of the 
experiment BW was similar in all groups (Table 1).  
Oral administration of ZpE (2.5, 5 or 10 mg GAE/day) did not modify PAM, HR, fasting 
glucose, creatinine or hematological parameters. TC level was statistically significantly reduced 
(about 47%) by the dose of 2.5 mg GAE/day (Table 1). Treatment with ZpE (5 or 10 mg GAE/day) 
reduced AST and direct bilirubin levels as compared with untreated rabbits (Table 1). 
No differences were found in the liver/ BW ratio or the heart /BW ratio between ZpE-treated 
and untreated groups. However, the kidney/BW ratio was increased in rabbits receiving 10 mg 
GAE/day of ZpE (Table 1).  
 
Experiment II: effect of oral administration of 2.5 mg GAE/day of ZpE in rabbits fed a high 
cholesterol diet  
 
Addition of cholesterol to the diet significantly increased TC, TG, bilirubin (total, direct and 
indirect) and AST levels as well as the liver/BW ratio, reduced hematocrit and increased white cells 
count (Table 2). The oral administration of ZpE 2.5 mg GAE/day reduced TC levels, normalized 
TG, bilirubin (total, direct and indirect) and AST levels, hematocrit, white cells count and did not 
modify the liver/BW ratio. In addition, administration of ZpE significantly reduced MAP in rabbits 
fed on HD. Treatment with equivalent doses (2.5 mg/day) of rosuvastatin did not reduce TC levels, 
normalized TG, direct bilirubin, AST levels, hematocrit, white cells and also reduced MAP. 
Analysis of HDL-C and LDL-C showed that neither ZpE nor rosuvastatin at doses used in the 
present study modify lipoprotein plasma profiles. 
Oxidative stress parameters 
Serum lipid peroxidation was significantly reduced by oral administration of ZpE (2.5 mg 














treated with ZpE compared with rabbits treated with vehicle (Fig 2b). Overall, these results imply 
that ZpE enhanced the serum antioxidant capacities under hypercholesterolemic conditions.  
Effects of oral treatment with 2.5 mg GAE/day of ZpE on vascular morphology 
Representative photographs of the morphological changes in the aorta from the five groups 
stained with hematoxylin-eosin method are shown in Supplement 1. Histological examination 
showed moderate thickening of the tunica intima in arteries from rabbits fed on HD. The 
administration of ZpE or rosuvastatin to rabbits fed on HD normalized the intima/media ratio (CD: 
0.05 ± 0.002 vs HD: 0.71 ± 0.04 vs ZpE-HD: 0.039 ± 0.003 vs Ro-HD: 0.04 ± 0.002; P < 0.01, one 
way ANOVA and Duncan´s post test). 





M) caused an endothelium-dependent relaxation in a 
concentration-responsive manner in all of the studied groups. Vessels derived from rabbits fed on 
HD demonstrated significantly impaired responses to acetylcholine (Fig.3).Administration of ZpE 
did not change acetylcholine relaxation in CD group and normalized the maximal relaxing effect of 
acetylcholine in the hypercholesterolemic group (RmaxCD: 66.2 ± 5.2% vs HD: 27.3 ± 3.8% vs ZpE-
CD: 60.5 ± 6.2% vs ZpE-HD: 65.9 ± 8% vs Ro-HD: 42.5 ± 4.2%; p < 0.05, two way ANOVA and 
Duncan´s post test). In addition, ZpE-treatment improved acetylcholine affinity in both diet groups 
(pEC50 CD: 7.01 ± 0.07 vs HD: 6.67 ± 0.11 vs ZpE-CD: 7.18 ± 0.05 vs ZpE-HD: 7.23 ± 0.08 vs 
Ro-HD: 7.06 ± 0.11; p < 0.05, two way ANOVA and Duncan´s post test). Treatment with 
rosuvastatin also improved Rmax and pEC50 to acetylcholine in hypercholesterolemic rabbits, but 
differences were not statistically significant.  
The endothelium-independent vasorelaxant response to sodium nitroprusside 5 x 10
−6
 M, a 
NO donor, was similar in all groups (CD: 94 ± 5% vs HD: 91.3 ± 3% vs ZpE-CD: 95 ± 2% vs ZpE-
HD: 91 ± 2% vs Ro-HD: 97.5 ± 0.8%). 
Rmax and pEC50 to norepinephrine was similar in rabbits fed on CD and rabbits fed on HD. 
The oral administration of ZpE reduced the affinity to norepinephrine in both diet groups and the 
Rmax only in rabbits fed on CD. Rosuvastatin increased affinity to norepinephrine (Fig.4). 
According to previous work (Jerez et al. 2008), results showed that HD increased Rmax and 
affinity to angiotensin II with respect to CD. The effect of ZpE-administration on angiotensin II 
contractile response was diet- dependent: reduced affinity in rabbits fed on CD and Rmax in rabbits 
fed on HD. Treatment with rosuvastatin also reduced significantly contractile response to 
angiotensin II in hypercholesterolemic rabbits (Fig.5). 
 
Discussion  
The antioxidant and anti-inflammatory activities of the ZpE and its major flavonoids have 
been demonstrated (Moran Vieyra et al. 2009). Recently, in vitro studies show that ZpE and its 
major flavonoids have vasorelaxant effect, sensitize acetylcholine-response, reduce phenylephrine 
vasoconstriction and antagonize angiotensin II-contractile response in arteries from 
hypercholesterolemic rabbits (Roco et al. 2017). However, at present there are no in vivo studies 
evaluating the effect of ZpE on hypercholesterolemia. Present study characterized the effect of the 
oral administration of a ZpE, rich in flavonoids, on a rabbit model of hypercholesterolemia induced 
by a HD. ZpE effectively lowered TC and TG levels by about 65% and 50% respectively, reduced 
oxidative stress parameters and PAM, normalized hematological parameters (hematocrit and white 
cells count) and improved vascular function. Even more, ZpE improved markers of liver function 














clinical and biochemical parameters except for TC levels. Li et al. (2016) show that rosuvastatin 
(1.5 mg/kg/day) reduces by about 30% TC and LDL-C in rabbits fed a HD. These authors do not 
find differences in TG levels between CD and HD animals. Thus, this difference in the lipid profile 
may account for our unexpected results.  
Oral administration of flavonoid-rich ZpE at dose of 2.5 mg GAE/ml was not toxic as there 
was no sedation, itching and mortality seen; no differences existed on weight gain, organ size (heart 
and kidney), liver and kidney function or hematological parameters in experimental rabbits. These 
results were in agreement with previous studies (Zampini et al. 2008).  
Flavonoids from various sources have been reported to show markedly hypolipidemic 
activity in vivo, suggesting the effectiveness of flavonoids for the prevention and treatment of 
atherosclerosis (Salvamani et al. 2014). In agreement with data from the bibliography (Agüero et al. 
2010; Moreno et al. 2015; Nuño et al. 2016), we found that the most dominants components of the 
aerial parts of Z. punctata were chalcones (DHC and MDHC). Various chemically diverse chalcone 
scaffolds have been reported to inhibit various cardiovascular targets such as angiotensin converting 
enzyme (ACE), calcium/potassium channels, TG synthesis, diacylglycerol acyltransferase (DGAT), 
cholesteryl ester transfer protein (CETP), pancreatic lipase (PL), acyl-coenzyme A: cholesterol 
acyltransferase (ACAT), and lipoprotein lipase (LPL) (Mahapatra and Bharti, 2016). Thus, the 
hypolipidemic activity of the ZpE may be attributed to its chalcones content. The mechanism of 
such effect will be the goal of further studies.  
The oral administration of 2.5 mg GAE/day ZpE reduced oxidative stress, restored 
acetylcholine relaxation and reduced aortic intima/media ratio reverting endothelial dysfunction in 
rabbits fed a HD. An imbalance between the production of ROS and the antioxidant defense 
mechanisms leading to oxidative stress has been suggested to contribute to the etiology and 
progression of the atherosclerosis (Singh et al. 2015). In hypercholesterolemic rabbits increased 
production of ROS has been implicated in the impairment of endothelial function (Ohara et al. 
1993; Mugge et al. 1991). Under oxidative stress, excess of superoxide reacts with NO to form 
peroxynitrites (ONOO), a reactive molecule that impairs NO-dependent vasodilation. Previous 
studies have reported beneficial effects of flavonoids on the endothelial function (Ajay and Mustafa 
2005; Hodgson and Croft 2006; Roco et al. 2017) as well as improved endothelial function 
following antioxidant interventions (Mugge et al. 1991; Papageorgiou et al. 2013). The 
enhancement of acetylcholine relaxation in aorta from HD rabbits treated with ZpE was consistent 
with these data. In this sense, the major flavonoids presents in ZpE, DHC and MDHC, are potent 
antioxidants and scavengers of ROS (Moran Vieyra et al. 2009; Moreno et al. 2015). Indeed, such 
antioxidant actions could contribute to restoring endothelial function in hypercholesterolemic 
rabbits. No changes in the response to the endothelium-independent vasorelaxant sodium 
nitroprusside in aorta from both diet groups either treated or not with the ZpE supported this view. 
In addition, increased sensitivity to acetylcholine was found in both diets groups. Some flavonoids 
increase endothelial NO synthase activity (Olszanecki et al. 2002; Duarte et al. 2012). Therefore, in 
such conditions a lower dose of acetylcholine should be necessary to achieve the same relaxant 
response. In hypercholesterolemic rabbits this mechanism would be additional to the antioxidant 
effects previously discussed and both together may contribute to the increased efficiency observed 
in HD. One of the characteristic morphological changes of atherosclerosis is increased intima/media 
ratio. Epidemiologic data have shown a clear correlation between this feature and cardiovascular 
disease. Thus, this parameter would be an early marker of atherosclerosis (Campuzano et al. 2003). 
Previously we found an increased intima/media ratio in aorta from rabbits fed a HD. Treatment with 
ZpE, as well as rosuvastatin, normalized intima/media ratio in aorta from hypercholesterolemic 
rabbits. This effect on vascular morphology supports the hypothesis that ZpE treatment may 














One of the objectives of the present work was to evaluate the ability of ZpE treatment to 
prevent the alterations on vascular responsiveness to vasoconstrictor agonists. Our results showed 
that oral administration of ZpE significantly desensitized the contractile response to norepinephrine 
both in normal and hypercholesterolemic rabbits. Consistent with these results, natural flavonoids 
were found to possess alpha1-adrenergic receptor antagonistic effects (Ajay et al. 2003; Duarte et 
al. 1993; Li et al.2011). Hypercholesterolemia induces alterations in vascular reactivity to 
angiotensin II (Jerez et al. 2008). Oral administration of ZpE had a diet-dependent effect on the 
angiotensin II-contractile response. Desensitization was found in rabbits fed on CD and reduction of 
the Rmax was found in rabbits fed on HD. Flavonoids have been shown to play a pivotal role in the 
inhibition of angiotensin II induced superoxide via activation of NADPH oxidase, a major source of 
superoxide generator (Lau et al. 2012). Therefore, angiotensin II effect of ZpE administration could 
be related with the antioxidant constituents of the extract, predominantly flavonoids. Moreover, 
previous work has shown improvement of angiotensin II-contractile response in aorta from rabbits 
fed on high cholesterol diet. Endothelial dysfunction caused by increasing cyclooxygenase activity 
ROS-dependent and releasing of vasoconstrictor prostanoids may account for this phenomenon 
(Jerez et al. 2008). Flavonoids from Z. punctata have been demonstrated to inhibit cyclooxygenase 
activity in vitro, in addition to its antioxidant properties (Moreno et al. 2015; Nuño et al. 2016). 
Futhermore, flavonoid inhibition of cyclooxygenase activity together with endothelial function 
improvement may contribute to reduce contractile response to angiotensin II in ZpE-treated rabbits.  
A low-order, positive relationship of dietary cholesterol intake to systolic blood pressure 
with control for multiple possible confounders has been reported (Sakurai et al. 2011). The 
improvements in endothelium-dependent relaxations to acetylcholine following chronic antioxidant 
treatments are associated with either reduced or no significant changes in MAP (Kitiyakara and 
Wilcox, 1998). Oral administration of ZpE significantly reduced mean MAP in rabbits fed on HD. 
Because the MAP measurements were recorded at the end of the treatment, reduction in the blood 
pressure was not caused by acute vasodilatory actions of the ZpE. Results from the present study 
demonstrated that the ZpE was an inhibitor of vasoconstriction induced by stimulation of 
physiologically important vascular receptors, such as adrenergic and angiotensin II receptors, which 
play a pivotal role in the regulation of blood pressure. Furthermore reduction of vasoconstrictor 
response together with its hypolipidemic properties may account for the MAP reduction induced by 
ZpE treatment in rabbits fed on HD. 
Although rosuvastatin did not improve relaxation to acetylcholine and increased 
norepinephrine affinity, it reduced angiotensin II contractile response. These data, taken together 
with no effect of rosuvastatin on TC levels, may imply differential role of lipids in the vascular 
dysfunction. Further study needs to be taken to understand the underlying mechanisms of these 
effects. 
In conclusion, the present study clearly demonstrated that oral administration of ZpE had no 
toxicity at doses used, reduced TC and TG levels, improved oxidative status preventing endothelial 
dysfunction and increase of contractile response to vasoconstrictors in rabbits fed on HD. 
Therefore, the use of ZpE as natural product in the prevention of cardiovascular disease related with 
hypercholesterolemia and endothelial dysfunction would be very promising. 
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Table 1. Mean arterial pressure (MAP), heart rate (HR), biochemical and hematological parameters 
and organ weights from rabbits treated with vehicle or 2.5, 5, 10 mg/day of Zuccagnia punctata 
extract  
 Vehicle 2.5 mg 5 mg 10 mg 
Weigth (g) 2088 ± 99 1920 ± 144 2200 ± 100 1957 ± 99 
PAM (mmHg) 60.5 ± 3.5 58.3 ± 2.5 79 ± 3.4 64.5 ± 0.5 
Fasting Glucose (mg/dl) 113.2 ± 2.7 119.2 ± 4.1 116.8 ± 6.7 125.8 ± 5.5 
Total Cholesterol (mg/dl) 66 ± 6.8 35.1 ± 6.1
a
 40.2 ± 11.3 58.4 ± 14.7 
Triglycerides (mg/dl) 97.4 ± 14.9 81.0 ± 20.6 90.1 ± 12  131.3 ± 15.4 
Creatinine (mg/dl) 0.81 ± 0.04 0.82 ± 0.2 0.81 ± 0.25 0.81 ± 0.25 
Aspartate amino 
transferase (U/l) 
21.3 ± 3.9 15.6 ± 0.6 4.2 ± 1.9
a
 3.0 ± 1.9
a
 
Alanine amino  
Transferase (U/l) 
20.5 ± 4 18.6 ± 0.5 20.4 ± 1.5 19 ± 1.9 
Total bilirubin (mg/dl) 0.32 ± 0.03 0.24 ± 0.01 0.32 ± 0.04 0.39 ± 0.11 
Direct bilirubin (mg/dl) 0.086 ± 0.02 0.07 ± 0.01 0.03 ± 0.01
a
 0.05 ± 0.01
a
 
Indirect bilirubin (mg/dl) 0.2 ± 0.03 0.17 ± 0.02 0.28 ± 0.04 0.30 ± 0.08 
Liver (% BW) 3.19 ± 0.14 2.87 ± 0.26 3.12 ± 0.16 3.5 ± 0.09 
Kidney (% BW) 0.34 ± 0.05 0.30 ± 0.01 0.32 ± 0.02 0.55 ± 0.16
a
 
Heart (% BW) 0.27 ± 0.02 0.22 ± 0.02 0.24 ± 0.01 0.26 ± 0.02 
Hematocrit (%) 41.1 ± 1.2 39 ± 1.6 41.9 ± 1.7 45 ± 1.2 




) 13.2 ± 2.1 10.6 ± 1.3 11.6 ± 2.5 13.0 ± 1.5 
 
Data are expressed as mean  ±  SE of 4 rabbits. 
a 
p < 0.05 indicates statistically significant 
differences between ZpE-treated and vehicle-treated rabbits. 
Table 2.Clinical and biochemical parameters from rabbits fed a control diet (CD) and a high 














 CD ZpE-CD HD ZpE-HD Ro-HD 
BodyWeight (g) 2088 ± 99 2037 ± 121 2188 ± 64 2086 ± 41 1860 ± 42 
PAM (mmHg) 60.5 ± 3.5 55.3 ± 3.7 73.2 ± 2.4 50 ± 2
b
 50.2 ± 4.6 
HR 277.6 ± 29 252 ± 10 226 ± 11 225 ± 5 230 ± 8 
Fasting Glucose 
(mg/dl) 
113.2 ± 2.7 120.7 ± 2.9 115.3 ± 3.5 129 ± 2 130 ± 11 
Total Cholesterol 
(mg/dl) 
78.4 ± 6.4 34.6 ± 3.7
b
 928 ± 99
a
 369 ± 84
b
 816 ± 225 
HDL-C 54.7 ± 2.8 12.2 ± 2
b
 115.5 ± 36
a
 16.5 ± 0.8
b
 16.5 ± 1.5
b
 
LDL-C 35.1 ± 2.3 8.4 ± 1.1
b
 692 ± 112 308 ± 76
a
 784 ± 195 
Triglycerides 
(mg/dl) 
97.4 ± 14.9 85.3 ± 14.8 215 ± 27 
a
 93.7 ± 15
b





0.81 ± 0.04 0.74 ± 0.14 0.97 ± 0.13 0.70 ± 0.2 0.94 ± 0.09 
Aspartate amino 
transferase (U/l) 









19.6 ± 3.9 24.6 ± 1.8 9.3 ± 1.9
a
 8.44 ± 1.2 7.4 ± 1.4 
Total bilirubin 
(mg/dl) 
0.32 ± 0.03 0.24 ± 0.01 0.65 ± 0.17
a
 0.24 ± 0.03
b
 0.43 ± 0.1 
Direct bilirubin 
(mg/dl) 
0.086 ± 0.02 0.07 ± 0.01 0.1 ± 0.05 0.06 ± 0.02
b





0.2 ± 0.03 0.17 ± 0.02 0.55 ± 0.15
a




0.41 ± 0.1 
Liver (% BW) 3.19 ± 0.14 2.96 ± 0.15 4.1 ± 0.2
a
 4.27 ± 0.2 4.9 ± 0.1 














Heart (% BW) 0.27 ± 0.02 0.24 ± 0.1 0.23 ± 0.03 0.23 ± 0.01 0.25 ± 0.1 
Hematocrit (%) 41.0 ± 1.2 39.0 ± 1.6 34.3 ± 1.0
a
 41.0 ± 2.9
b






)   
12.2 ± 2.1 10.6 ± 1.3 16.7 ± 1.5
a
 12.3 ± 0.8
b




Data are expressed as mean  ±  SE of 8 rabbits. ZpE: hydroalcoholic extract from Z. Punctata. Ro: 
rosuvastatin.
 a 
p < 0.05 indicates statistically significant differences between rabbits fed a CD and 
rabbits fed a HD.
b 
p < 0.05 indicates statistically significant differences between ZpE or Ro-treated 















Fig. 1. RP-HPLC chromatogram of hydroalcoholic Zuccagnia punctata extract at 330 nm for 
identification and quantification of major flavonoids: 2′,4′-dihydroxy-3′-methoxychalcone 
(DHMC);  2′,4′-dihydroxychalcone (DHC). 
 
 
Fig. 2. Effects of 2.5 mg/day hydroalcoholic Z. punctata extract  (ZpE) treatment on serum 
oxidative parameters: lipid peroxidation (TBARS) (a) and ratio of reduced glutathione to oxidized 
glutathione (GSH/GSSH) (b).  
 
Fig. 3. Concentration response curves to acetylcholine in aortic rings from: CD: rabbits fed a 
control diet; HD rabbits fed a high cholesterol diet (HD); ZpE-CD: rabbits fed a control diet and 














cholesterol diet and treated with 2.5 mg/day of hydroalcoholic Z. punctata extract. *p < 0.05 
indicates statistically significant differences in maximal relaxation between HD and ZpE-HD 
arteries (one way ANOVA). 
 
Fig. 4. Concentration response curves to norepinephrine in aortic rings from: CD: rabbits fed a 
control diet; HD rabbits fed a high cholesterol diet (HD); ZpE-CD: rabbits fed a control diet and 
treated with 2.5 mg/day of hydroalcoholic Z. punctata extract; ZpE-HD: rabbits fed a high 
cholesterol diet and treated with 2.5 mg/day of hydroalcoholic Z. punctata extract. Ro-HD: rabbits 
fed a high cholesterol diet and treated with 2.5 mg/day of rosuvastatin. * p < 0.05 indicates 
statistically significant differences between maximal response of HD with respect to CD, ZpE-CD 
and ZpE-HD (one way ANOVA). ƒ p < 0.05 indicates statistically significant differences in pEC50 
















Fig. 5. Concentration response curves to angiotensin II in aortic rings from: CD: rabbits fed a 
control diet; HD rabbits fed a high cholesterol diet (HD); ZpE-CD: rabbits fed a control diet and 
treated with 2.5 mg/day of hydroalcoholic Z. punctata extract; ZpE-HD: rabbits fed a high 
cholesterol diet and treated with 2.5 mg/day of hydroalcoholic Z. punctata extract; Ro-HD: rabbits 
fed a high cholesterol diet and treated with 2.5 mg/day of rosuvastatin. *p < 0.05 indicates 
statistically significant differences in maximal response between HD, ZpE-HD and Ro-HD. ƒ p < 
0.05 indicates statistically significant differences in pEC50 between CD and ZpE-
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